Xixi Lin

1.9k total citations · 1 hit paper
67 papers, 1.5k citations indexed

About

Xixi Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xixi Lin has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 23 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Xixi Lin's work include Bone Metabolism and Diseases (24 papers), Bone health and treatments (15 papers) and Asthma and respiratory diseases (7 papers). Xixi Lin is often cited by papers focused on Bone Metabolism and Diseases (24 papers), Bone health and treatments (15 papers) and Asthma and respiratory diseases (7 papers). Xixi Lin collaborates with scholars based in China, Australia and United States. Xixi Lin's co-authors include Jinmin Zhao, Jiake Xu, Qiang-min Xie, Yong-liang Jia, Fangming Song, Weixi Zhang, Huijuan Shen, Jichun Zhou, Jian Shen and Xinwei Dong and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Xixi Lin

62 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities

2022 174 citations Xixi Lin, Jichun Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xixi Lin China	24	845	341	231	207	172	67	1.5k
Hongzhi Sun China	26	935 1.1×	258 0.8×	274 1.2×	106 0.5×	118 0.7×	71	1.7k
Chun‐Yin Huang Taiwan	30	1.2k 1.4×	463 1.4×	411 1.8×	321 1.6×	135 0.8×	60	2.2k
Yongheng Bai China	26	990 1.2×	331 1.0×	254 1.1×	254 1.2×	182 1.1×	74	1.9k
Cristina Sánchez‐de‐Diego Spain	14	842 1.0×	523 1.5×	379 1.6×	132 0.6×	218 1.3×	26	1.8k
Ayoung Kim South Korea	16	968 1.1×	221 0.6×	511 2.2×	92 0.4×	79 0.5×	33	1.7k
Dahn L. Clemens United States	27	733 0.9×	344 1.0×	105 0.5×	135 0.7×	104 0.6×	73	2.4k
Chae Hwa Kwon South Korea	26	1.0k 1.2×	452 1.3×	327 1.4×	179 0.9×	373 2.2×	55	1.9k
Wei Niu China	24	1.2k 1.4×	482 1.4×	185 0.8×	174 0.8×	246 1.4×	71	2.2k
Anna Maria D’Alessandro Italy	22	639 0.8×	534 1.6×	101 0.4×	107 0.5×	134 0.8×	53	1.7k

Countries citing papers authored by Xixi Lin

Since Specialization

Citations

This map shows the geographic impact of Xixi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xixi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xixi Lin more than expected).

Fields of papers citing papers by Xixi Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xixi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xixi Lin. The network helps show where Xixi Lin may publish in the future.

Co-authorship network of co-authors of Xixi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xixi Lin. A scholar is included among the top collaborators of Xixi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xixi Lin. Xixi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Xixi, et al.. (2025). Conception and Concern: A Review of Breast Cancer Risk in Assisted Reproductive Technology. International Journal of Biological Sciences. 21(6). 2647–2671.

Zhu, Ziyu, et al.. (2025). Efficacy of cyclin-dependent kinase inhibitors with concurrent proton pump inhibitors in patients with breast cancer: a systematic review and meta-analysis. The Oncologist. 30(2).

Li, Na, Jie Han, Xixi Lin, et al.. (2025). Expression of Concern for Axon guidance cue SLIT2 regulates the murine skeletal stem cell niche through sympathetic innervation. Journal of Clinical Investigation. 135(24). 1 indexed citations

Lin, Xixi, Guixin Yuan, Bin Yang, et al.. (2024). Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity. Phytomedicine. 129. 155559–155559. 8 indexed citations

Dai, Yilong, Fei Zhao, Qian Chen, et al.. (2024). P-790 Engineering Vascularized Human Endometrial Organoids for In Vivo Tissue Regeneration and Repair Applications. Human Reproduction. 39(Supplement_1). 1 indexed citations

Zhu, Ziyu, Xixi Lin, Yue Wen, et al.. (2024). Tumor microenvironment and immunotherapy for triple-negative breast cancer. Biomarker Research. 12(1). 166–166. 22 indexed citations

Lin, Xixi, et al.. (2023). Incidence and risk factors of lymph node metastasis in breast cancer patients without preoperative chemoradiotherapy and neoadjuvant therapy: analysis of SEER data. Gland Surgery. 12(11). 1508–1524. 1 indexed citations

Song, Dezhi, Xixi Lin, Hui Peng, et al.. (2023). Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL‐induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation. Free Radical Biology and Medicine. 196. 121–132. 15 indexed citations

Wan, Jin‐Yi, Jingjing Song, Qingqing Lv, et al.. (2023). Alterations in the Gut Microbiome of Young Children with Airway Allergic Disease Revealed by Next-Generation Sequencing. Journal of Asthma and Allergy. Volume 16. 961–972. 10 indexed citations

10.

Chen, Yongjie, Linlin Zhang, Xixi Lin, et al.. (2022). Mogrol Attenuates Osteoclast Formation and Bone Resorption by Inhibiting the TRAF6/MAPK/NF-κB Signaling Pathway In vitro and Protects Against Osteoporosis in Postmenopausal Mice. Frontiers in Pharmacology. 13. 803880–803880. 15 indexed citations

11.

Liang, Jiamin, Kun Tian, Zhigang Che, et al.. (2020). Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice. Frontiers in Pharmacology. 10. 1587–1587. 23 indexed citations

12.

Wang, Like, et al.. (2020). Diplatin, a novel water-soluble platinum complex, inhibits lung cancer growth via augmentation of Fas-mediated apoptosis. European Journal of Pharmacology. 879. 173128–173128. 2 indexed citations

13.

Yuan, Guixin, Xixi Lin, Li Li, et al.. (2019). Vx-11e protects against titanium-particle-induced osteolysis and osteoclastogenesis by supressing ERK activity. Biochemical and Biophysical Research Communications. 514(4). 1244–1250. 6 indexed citations

14.

Huang, Yue, et al.. (2019). Vitamin D alleviates airway remodeling in asthma by down-regulating the activity of Wnt/β-catenin signaling pathway. International Immunopharmacology. 68. 88–94. 30 indexed citations

15.

Lin, Xixi, et al.. (2018). Celastrol Alleviates Airway Hyperresponsiveness and Inhibits Th17 Responses in Obese Asthmatic Mice. Frontiers in Pharmacology. 9. 49–49. 34 indexed citations

16.

Ye, Weijian, Ruijie Chen, Wei Sun, et al.. (2017). Determination and pharmacokinetics of engeletin in rat plasma by ultra-high performance liquid chromatography with tandem mass spectrometry. Journal of Chromatography B. 1060. 144–149. 42 indexed citations

17.

Zhang, Shui-juan, Qianqian Ren, Yong-liang Jia, et al.. (2016). Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathway. European Journal of Pharmacology. 775. 138–148. 24 indexed citations

18.

Tan, Zhen, Jianwen Cheng, Qian Liu, et al.. (2016). Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice. Molecular and Cellular Endocrinology. 439. 369–378. 37 indexed citations

19.

Lin, Xixi, Junxia Jiang, Shui-juan Zhang, et al.. (2014). Cigarette smoke extract-induced BEAS-2B cell apoptosis and anti-oxidative Nrf-2 up-regulation are mediated by ROS-stimulated p38 activation. Toxicology Mechanisms and Methods. 24(8). 575–583. 34 indexed citations

20.

Zhang, Linhui, Yong-liang Jia, Xixi Lin, et al.. (2013). AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen species. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(8). 4148–4159. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact